Askgene Pharma Inc.

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Jiangsu Aosaikang Ph

Kurt Shanebeck

Jian-Feng Lu

Yuefeng Lu

Lan Yang

Lu Li

Lei Liu

Donggou He

Chen Yao

Shiwen Zhang

Aijun Wang

Fang Xia

Described and provided herein are novel antibodies for Claudin 18.2. Also described and provided are pharmaceutical compositions of the antibodies and methods of use for the treatment of cancer.

Antibodies and methods for making and using the same

The present specification discloses erythropoietin receptor agonists, compositions and medicaments comprising such erythropoietin receptor agonists, methods and uses for such erythropoietin receptor agonists and compositions and medicaments, and methods and uses for erythropoietin receptor agonists and compositions and medicaments for treating an anemia.

Feline erythropoietin receptor agonists

The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.

PD-L1 specific monoclonal antibodies for disease treatment and diagnosis

Growing community of inventors

Camarillo, CA, United States of America

Kurt Shanebeck